SA33 Real-World Cardiac Safety of Anti-HER2 Therapies in Elderly Patients with HER2+/HR-Metastatic Breast Cancer: A Retrospective Cohort Study Using SEER-Medicare DATA 2012-2016. - Ou, Z; Nohria, A; Spring, LM; Seeger, JD; Doucette, J; Murimi-Worstell, IB (Value in Health, 2022)